Population Group
FDA Approves Long-Established European UTI Antibiotic by Utility Therapeutics
Utility Therapeutics, FDA, UTI antibiotic, European market, 40-plus years.
FDA Greenlights UTILITY’s Innovative Antibiotic for Simple Urinary Tract Infections in Women
FDA, UTILITY, antibiotic, uncomplicated UTI, women, approval, innovative, treatment, urinary tract infection
From Alpine’s Elite Data Room to Vertex’s VIP: A Shift in Biotech Dominance
Alpine, Vertex, biotech, data room, exclusivity, VIP, shift, dominance.
Landmark Federal Data Privacy Proposal Unveiled
Federal Data Privacy, Public Showcase, Proposal, Consumer Rights, Privacy Law
Vertex’s Acquisition of Alpine Immune Sciences for Povetacicept: Humira-like Potential in IgAN, but Indication Variations Matter
Vertex, Alpine Immune Sciences, Povetacicept (ALPN-303), IgA nephropathy (IgAN), Humira-like potential, Multiple autoimmune diseases
Boehringer Ingelheim Caps Out-of-Pocket Costs for Asthma and COPD Inhalers in the U.S.
Boehringer Ingelheim, Out-of-pocket costs, Asthma, COPD, Inhalers, $35 cap, June 1/ 2024, Uninsured and under-insured patients, List price reduction
ViiV’s Long-Acting Cabenuva Outperforms Daily Oral Therapy in Phase III Study
cabenuva, Daily, Standard of Care, Adherence (attribute), HIV, Participant, daily